COMPLETED

Reducing COVID-19 Vaccine Hesitancy Among Hispanic Parents

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

COVID-19 vaccines are available to children over six months, and these vaccines are powerful tools against this catastrophic pandemic. However, Hispanic/Latino children have lower COVID-19 vaccination rates than White non-Hispanic children .Our team of health communication and public health experts proposes a community-based theory-driven intervention that utilizes culturally-grounded narratives from digital storytelling to reduce Hispanic parents' COVID-19 vaccine hesitancy and increase their children's vaccine uptake.

Official Title

Reducing Vaccine Hesitancy Among Hispanic Parents of COVID-19 Vaccine-Eligible Children

Quick Facts

Study Start:2024-07-01
Study Completion:2025-07-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06036134

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * self-identifies as Hispanic
  2. * is a biological parent or a legal guardian of at least one child under 18 years old
  3. * their child(ren) are not vaccinated against up-to-date with COVID-19 vaccine doses
  4. * agrees to send and receive a text message and submit a photo of their child's immunization record for T3 data collection.
  1. * individuals who do not meet inclusion criteria or are unable/ unwilling to provide consent.

Contacts and Locations

Principal Investigator

Alexis Koskan, Ph.D
PRINCIPAL_INVESTIGATOR
Arizona State University
Sunny W Kim, Ph.D
PRINCIPAL_INVESTIGATOR
Arizona State University

Study Locations (Sites)

Arizona State University
Phoenix, Arizona, 85004
United States

Collaborators and Investigators

Sponsor: Arizona State University

  • Alexis Koskan, Ph.D, PRINCIPAL_INVESTIGATOR, Arizona State University
  • Sunny W Kim, Ph.D, PRINCIPAL_INVESTIGATOR, Arizona State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-01
Study Completion Date2025-07-30

Study Record Updates

Study Start Date2024-07-01
Study Completion Date2025-07-30

Terms related to this study

Keywords Provided by Researchers

  • COVID-19 Vaccine
  • Digital storytelling
  • Hispanic children
  • Vaccine hesitancy
  • Health disparities

Additional Relevant MeSH Terms

  • Vaccine-Preventable Diseases
  • COVID-19 Pandemic
  • Health-Related Behavior
  • Health Knowledge, Attitudes, Practice
  • Narration